STOCKHOLM – When Attana, an 11-year-old Swedish biosensor company, introduced its Cell 200 system two years ago, it envisioned a future where its revenues would be driven by instrument placements and consumables sales.

However, the reaction of Attana's pharmaceutical company clients to the Cell 200, which can be used to measure kinetic molecular reactions in cells, presented the company with an unexpected challenge, Thomas Ljungberg, the company's international sales manager, told BioArray News during an interview here this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.